ESCMID eAcademy

ePosters are only viewable by those with a valid ECCMID 2021 registration.
If you already have a registration, please login to the online platform here.
If you are not yet registered, you can do so here.
Abstract
Discussion Forum (0)
Abstract number: 755

Session Type: ePosters

Session Title: ePosters

Authors(s): V. De Sario (1), S. Morris-Jones (1), P. Grant (2), A. Ward (2), S. De (1)

Authors Affiliations(s): (1) University College London Hospital - London (United Kingdom) - London (United Kingdom), United Kingdom, (2) Health Services Laboratories, United Kingdom

Background:

Broad–range 16S ribosomal RNA gene polymerase chain reaction (16S-PCR) is a routinely-utilised assay.  As part of a retrospective validation of novel species-specific real-time PCR (RT-PCR) assays, we evaluated samples tested in our laboratory over 3 years.

 

Methods:

Samples undergoing routine culture and referred for molecular investigations were tested on an in-house assay, utilising conventional PCR targeting the V1-V2 regions of the 16S-rRNA gene. Positive amplicons were sequenced using Sanger methodology. Species-specific assays utilising RT-PCR probes targeting S. aureus femA/mecA, S. pneumoniae, S. pyogenes, S. agalactiae, L. monocytogenes, H. influenzae, N. meningitidis and Mycobacterium spp., were performed at the discretion of the duty microbiologist; targets were selected according to the clinical context.
 

 

Results:

Between September 2017 and September 2020, 955 samples from UCLH NHS Trust underwent 16S-PCR, including 183 for species-specific PCR. 

Samples were from a variety of sterile sites, including 301 neurosurgical and 197 orthopaedic specimens.

16S-PCR was positive in 330 (34.5%). Amongst the positive samples, 60 (20%) had positive, concordant microscopy, 104 (10.9%) had positive, concordant culture with 22 (2.3%) yielding a different culture result and 188 (19.7%) were culture-negative. 49 specimens were 16S-PCR-positive without species identification (probably due to mixed bacterial populations). Of the 16S-PCR-negative samples 73 (7.6%) were ultimately culture-positive. A wide-range of organisms were detected (Table 1).

Species-specific PCR was tested in 183 samples and was positive in 33 (18%) and detected 8 further positive results where 16S-PCR was negative. Concordance with 16S-PCR-positives was almost universal; one positive Mycobacterium sp. RT-PCR coinciding with Fusobacterium nucleatum on 16S-PCR, which could have been undetected otherwise (Table 2a and 2b).

Conclusions:

Molecular methods identified a significant number of organisms in culture-negative specimens. Positive 16S-PCR was strongly associated with positive microscopy. Mixed cultures were problematic for 16S-PCR species identification. However combining culture with 16S-PCR and more sensitive species-specific-PCR assays maximised detection of significant pathogens.

Keyword(s): 16S, PCR, rRNA

Abstract number: 755

Session Type: ePosters

Session Title: ePosters

Authors(s): V. De Sario (1), S. Morris-Jones (1), P. Grant (2), A. Ward (2), S. De (1)

Authors Affiliations(s): (1) University College London Hospital - London (United Kingdom) - London (United Kingdom), United Kingdom, (2) Health Services Laboratories, United Kingdom

Background:

Broad–range 16S ribosomal RNA gene polymerase chain reaction (16S-PCR) is a routinely-utilised assay.  As part of a retrospective validation of novel species-specific real-time PCR (RT-PCR) assays, we evaluated samples tested in our laboratory over 3 years.

 

Methods:

Samples undergoing routine culture and referred for molecular investigations were tested on an in-house assay, utilising conventional PCR targeting the V1-V2 regions of the 16S-rRNA gene. Positive amplicons were sequenced using Sanger methodology. Species-specific assays utilising RT-PCR probes targeting S. aureus femA/mecA, S. pneumoniae, S. pyogenes, S. agalactiae, L. monocytogenes, H. influenzae, N. meningitidis and Mycobacterium spp., were performed at the discretion of the duty microbiologist; targets were selected according to the clinical context.
 

 

Results:

Between September 2017 and September 2020, 955 samples from UCLH NHS Trust underwent 16S-PCR, including 183 for species-specific PCR. 

Samples were from a variety of sterile sites, including 301 neurosurgical and 197 orthopaedic specimens.

16S-PCR was positive in 330 (34.5%). Amongst the positive samples, 60 (20%) had positive, concordant microscopy, 104 (10.9%) had positive, concordant culture with 22 (2.3%) yielding a different culture result and 188 (19.7%) were culture-negative. 49 specimens were 16S-PCR-positive without species identification (probably due to mixed bacterial populations). Of the 16S-PCR-negative samples 73 (7.6%) were ultimately culture-positive. A wide-range of organisms were detected (Table 1).

Species-specific PCR was tested in 183 samples and was positive in 33 (18%) and detected 8 further positive results where 16S-PCR was negative. Concordance with 16S-PCR-positives was almost universal; one positive Mycobacterium sp. RT-PCR coinciding with Fusobacterium nucleatum on 16S-PCR, which could have been undetected otherwise (Table 2a and 2b).

Conclusions:

Molecular methods identified a significant number of organisms in culture-negative specimens. Positive 16S-PCR was strongly associated with positive microscopy. Mixed cultures were problematic for 16S-PCR species identification. However combining culture with 16S-PCR and more sensitive species-specific-PCR assays maximised detection of significant pathogens.

Keyword(s): 16S, PCR, rRNA

Evaluation and correlation of broad-range bacterial 16S-rRNA gene-PCR with species-specific PCR and culture results: experience of a London teaching hospital
Dr. Valentina De Sario
Dr. Valentina De Sario
ESCMID eAcademy. De Sario V. 07/09/2021; 327773; 755
user
Dr. Valentina De Sario
Abstract
Discussion Forum (0)
Abstract number: 755

Session Type: ePosters

Session Title: ePosters

Authors(s): V. De Sario (1), S. Morris-Jones (1), P. Grant (2), A. Ward (2), S. De (1)

Authors Affiliations(s): (1) University College London Hospital - London (United Kingdom) - London (United Kingdom), United Kingdom, (2) Health Services Laboratories, United Kingdom

Background:

Broad–range 16S ribosomal RNA gene polymerase chain reaction (16S-PCR) is a routinely-utilised assay.  As part of a retrospective validation of novel species-specific real-time PCR (RT-PCR) assays, we evaluated samples tested in our laboratory over 3 years.

 

Methods:

Samples undergoing routine culture and referred for molecular investigations were tested on an in-house assay, utilising conventional PCR targeting the V1-V2 regions of the 16S-rRNA gene. Positive amplicons were sequenced using Sanger methodology. Species-specific assays utilising RT-PCR probes targeting S. aureus femA/mecA, S. pneumoniae, S. pyogenes, S. agalactiae, L. monocytogenes, H. influenzae, N. meningitidis and Mycobacterium spp., were performed at the discretion of the duty microbiologist; targets were selected according to the clinical context.
 

 

Results:

Between September 2017 and September 2020, 955 samples from UCLH NHS Trust underwent 16S-PCR, including 183 for species-specific PCR. 

Samples were from a variety of sterile sites, including 301 neurosurgical and 197 orthopaedic specimens.

16S-PCR was positive in 330 (34.5%). Amongst the positive samples, 60 (20%) had positive, concordant microscopy, 104 (10.9%) had positive, concordant culture with 22 (2.3%) yielding a different culture result and 188 (19.7%) were culture-negative. 49 specimens were 16S-PCR-positive without species identification (probably due to mixed bacterial populations). Of the 16S-PCR-negative samples 73 (7.6%) were ultimately culture-positive. A wide-range of organisms were detected (Table 1).

Species-specific PCR was tested in 183 samples and was positive in 33 (18%) and detected 8 further positive results where 16S-PCR was negative. Concordance with 16S-PCR-positives was almost universal; one positive Mycobacterium sp. RT-PCR coinciding with Fusobacterium nucleatum on 16S-PCR, which could have been undetected otherwise (Table 2a and 2b).

Conclusions:

Molecular methods identified a significant number of organisms in culture-negative specimens. Positive 16S-PCR was strongly associated with positive microscopy. Mixed cultures were problematic for 16S-PCR species identification. However combining culture with 16S-PCR and more sensitive species-specific-PCR assays maximised detection of significant pathogens.

Keyword(s): 16S, PCR, rRNA

Abstract number: 755

Session Type: ePosters

Session Title: ePosters

Authors(s): V. De Sario (1), S. Morris-Jones (1), P. Grant (2), A. Ward (2), S. De (1)

Authors Affiliations(s): (1) University College London Hospital - London (United Kingdom) - London (United Kingdom), United Kingdom, (2) Health Services Laboratories, United Kingdom

Background:

Broad–range 16S ribosomal RNA gene polymerase chain reaction (16S-PCR) is a routinely-utilised assay.  As part of a retrospective validation of novel species-specific real-time PCR (RT-PCR) assays, we evaluated samples tested in our laboratory over 3 years.

 

Methods:

Samples undergoing routine culture and referred for molecular investigations were tested on an in-house assay, utilising conventional PCR targeting the V1-V2 regions of the 16S-rRNA gene. Positive amplicons were sequenced using Sanger methodology. Species-specific assays utilising RT-PCR probes targeting S. aureus femA/mecA, S. pneumoniae, S. pyogenes, S. agalactiae, L. monocytogenes, H. influenzae, N. meningitidis and Mycobacterium spp., were performed at the discretion of the duty microbiologist; targets were selected according to the clinical context.
 

 

Results:

Between September 2017 and September 2020, 955 samples from UCLH NHS Trust underwent 16S-PCR, including 183 for species-specific PCR. 

Samples were from a variety of sterile sites, including 301 neurosurgical and 197 orthopaedic specimens.

16S-PCR was positive in 330 (34.5%). Amongst the positive samples, 60 (20%) had positive, concordant microscopy, 104 (10.9%) had positive, concordant culture with 22 (2.3%) yielding a different culture result and 188 (19.7%) were culture-negative. 49 specimens were 16S-PCR-positive without species identification (probably due to mixed bacterial populations). Of the 16S-PCR-negative samples 73 (7.6%) were ultimately culture-positive. A wide-range of organisms were detected (Table 1).

Species-specific PCR was tested in 183 samples and was positive in 33 (18%) and detected 8 further positive results where 16S-PCR was negative. Concordance with 16S-PCR-positives was almost universal; one positive Mycobacterium sp. RT-PCR coinciding with Fusobacterium nucleatum on 16S-PCR, which could have been undetected otherwise (Table 2a and 2b).

Conclusions:

Molecular methods identified a significant number of organisms in culture-negative specimens. Positive 16S-PCR was strongly associated with positive microscopy. Mixed cultures were problematic for 16S-PCR species identification. However combining culture with 16S-PCR and more sensitive species-specific-PCR assays maximised detection of significant pathogens.

Keyword(s): 16S, PCR, rRNA

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies